Kesharwani P - Search Results

1

Advances in liposome-based delivery of RNA therapeutics for cancer treatment.

Sanati M, Afshari AR, Ahmadi SS, Kesharwani P, Sahebkar A. Sanati M, et al. Among authors: kesharwani p. Prog Mol Biol Transl Sci. 2024;204:177-218. doi: 10.1016/bs.pmbts.2023.12.010. Epub 2024 Jan 5. Prog Mol Biol Transl Sci. 2024. PMID: 38458738 Review.

2

Harnessing Therapeutic Potentials of Statins Using Nanofibrous Carriers.

Ataei M, Roufogalis BD, Kesharwani P, Jamialahmadi T, Sahebkar A. Ataei M, et al. Among authors: kesharwani p. Bioinorg Chem Appl. 2021 Nov 2;2021:7265505. doi: 10.1155/2021/7265505. eCollection 2021. Bioinorg Chem Appl. 2021. PMID: 34764991 Free PMC article. Review.

3

Drug repurposing strategies and key challenges for COVID-19 management.

Mule S, Singh A, Greish K, Sahebkar A, Kesharwani P, Shukla R. Mule S, et al. Among authors: kesharwani p. J Drug Target. 2022 Apr;30(4):413-429. doi: 10.1080/1061186X.2021.2013852. Epub 2021 Dec 9. J Drug Target. 2022. PMID: 34854327 Review.

4

3D-QSAR Studies of 1,2,4-Oxadiazole Derivatives as Sortase A Inhibitors.

Shakour N, Hadizadeh F, Kesharwani P, Sahebkar A. Shakour N, et al. Among authors: kesharwani p. Biomed Res Int. 2021 Dec 6;2021:6380336. doi: 10.1155/2021/6380336. eCollection 2021. Biomed Res Int. 2021. PMID: 34912894 Free PMC article.

5

Reactive Oxygen Species-Responsive Drug Delivery Systems: A New Approach in Nanomedicine.

Mirhadi E, Majeed M, Kesharwani P, Sahebkar A. Mirhadi E, et al. Among authors: kesharwani p. Curr Med Chem. 2022;29(25):4320-4323. doi: 10.2174/0929867329666220127110654. Curr Med Chem. 2022. PMID: 35086442 No abstract available.

6

Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways.

Afshari AR, Sanati M, Mollazadeh H, Kesharwani P, Johnston TP, Sahebkar A. Afshari AR, et al. Among authors: kesharwani p. Semin Cancer Biol. 2022 Nov;86(Pt 2):860-872. doi: 10.1016/j.semcancer.2022.01.008. Epub 2022 Feb 1. Semin Cancer Biol. 2022. PMID: 35115226 Review.

7

Polymeric nanomicelles of curcumin: Potential applications in cancer.

Farhoudi L, Kesharwani P, Majeed M, Johnston TP, Sahebkar A. Farhoudi L, et al. Among authors: kesharwani p. Int J Pharm. 2022 Apr 5;617:121622. doi: 10.1016/j.ijpharm.2022.121622. Epub 2022 Feb 26. Int J Pharm. 2022. PMID: 35227805 Review.

8

Stimuli-Responsive Microneedles as a Transdermal Drug Delivery System: A Demand-Supply Strategy.

Gowda BHJ, Ahmed MG, Sahebkar A, Riadi Y, Shukla R, Kesharwani P. Gowda BHJ, et al. Among authors: kesharwani p. Biomacromolecules. 2022 Apr 11;23(4):1519-1544. doi: 10.1021/acs.biomac.1c01691. Epub 2022 Mar 11. Biomacromolecules. 2022. PMID: 35274937 Review.

9

Recent advances in nanotechnology based combination drug therapy for skin cancer.

Kumari S, Choudhary PK, Shukla R, Sahebkar A, Kesharwani P. Kumari S, et al. Among authors: kesharwani p. J Biomater Sci Polym Ed. 2022 Aug;33(11):1435-1468. doi: 10.1080/09205063.2022.2054399. Epub 2022 Mar 24. J Biomater Sci Polym Ed. 2022. PMID: 35294334 Review.

10

Clinical progress of therapeutics and vaccines: Rising hope against COVID-19 treatment.

Bandaru R, Rout SR, Kamble OS, Samal SK, Gorain B, Sahebkar A, Ahmed FJ, Kesharwani P, Dandela R. Bandaru R, et al. Among authors: kesharwani p. Process Biochem. 2022 Jul;118:154-170. doi: 10.1016/j.procbio.2022.04.011. Epub 2022 Apr 14. Process Biochem. 2022. PMID: 35437418 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters